Prevalence and predictors of appropriate colorectal cancer surveillance in lynch syndrome

American Journal of Gastroenterology

Volumn 105, Issue 8, 2010, Pages 1851-1860

  Stoffel, Elena M ^a,b,c   Mercado, Rowena C ^b   Kohlmann, Wendy ^d   Ford, Beth ^b   Grover, Shilpa ^a   Conrad, Peggy ^e   Blanco, Amie ^e   Shannon, Kristen M ^f   Powell, Mark ^b   Chung, Daniel C ^c,f   Terdiman, Jonathan ^e   Gruber, Stephen B ^d   Syngal, Sapna ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MISMATCH REPAIR PROTEIN;

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CLINICAL ASSESSMENT; COLONOSCOPY; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SCREENING; GROUPS BY AGE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; PATIENT COMPLIANCE; PATIENT REFERRAL; PRACTICE GUIDELINE; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RELATIVE; RISK ASSESSMENT;

ADULT; COLONOSCOPY; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT COMPLIANCE; POPULATION SURVEILLANCE; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; UNITED STATES;

EID: 77955423711     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.120     Document Type: Article

References (32)

1. Hampel H, Frankel WL, Martin E et al. Screening for the Lynch syndrome(hereditary nonpolyposis colorectal cancer). N Engl J Med 2005; 352: 1851-1860.
2. Aarnio M, Sankila R, Pukkala E et al. Cancer risk in mutation carriers ofDNA-mismatch-repair genes. Int J Cancer 1999; 81: 214-218
3. Ramsey SD, Clarke L, Etzioni R et al. Cost-effectiveness of microsatelliteinstability screening as a method for detecting hereditary nonpolyposiscolorectal cancer. Ann Intern Med 2001; 135 (8 Pt 1): 577-588
4. Umar A, Boland CR, Terdiman JP et al. Revised Bethesda Guidelines forhereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatelliteinstability. J Natl Cancer Inst 2004; 96: 261-268 (Pubitemid 38256271)
5. American Gastroenterological Association. American GastroenterologicalAssociation medical position statement: hereditary colorectal cancer andgenetic testing. Gastroenterology 121: 195-197
6. Lindor NM, Petersen GM, Hadley DW et al. Recommendations for thecare of individuals with an inherited predisposition to Lynch syndrome: asystematic review. JAMA 2006; 296: 1507-1517
7. Jarvinen HJ, Aarnio M, Mustonen H et al. Controlled 15-year trial onscreening for colorectal cancer in families with hereditary nonpolyposiscolorectal cancer. Gastroenterology 2000; 118: 829-834
8. Mecklin JP, Aarnio M, Laara E et al. Development of colorectal tumorsin colonoscopic surveillance in lynch syndrome. Gastroenterology2007; 133: 1093-1098
9. de Vos tot Nederveen Cappel WH, Nagengast FM, Griffioen G et al. Surveillancefor hereditary nonpolyposis colorectal cancer: a long-term studyon 114 families. Dis Colon Rectum 2002; 45: 1588-1594
10. Giardiello FM, Brensinger JD, Petersen GM. AGA technical reviewon hereditary colorectal cancer and genetic testing. Gastroenterology2001; 121: 198-213.
11. Vasen HF, Moslein G, Alonso A et al. Guidelines for the clinical managementof Lynch syndrome (hereditary non-polyposis cancer). J Med Genet2007; 44: 353-362
12. Stoffel EM, Garber JE, Grover S et al. Cancer surveillance is oft en inadequatein people at high risk for colorectal cancer. J Med Genet 2003; 40: e54.
13. Stanley AJ, GaffCL, Aittomaki AK et al. Value of predictive genetic testingin management of hereditary non-polyposis colorectal cancer (HNPCC).Med J Aust 2000; 172: 313-316
14. Hadley DW, Jenkins JF, Dimond E et al. Colon cancer screening practicesaft er genetic counseling and testing for hereditary nonpolyposis colorectalcancer. J Clin Oncol 2004; 22: 39-44.
15. Halbert CH, Lynch H, Lynch J et al. Colon cancer screening practices followinggenetic testing for hereditary nonpolyposis colon cancer (HNPCC)mutations. Arch Intern Med 2004; 164: 1881-1887.
16. Wagner A, van Kessel I, Kriege MG et al. Long term follow-up of HNPCCgene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures. Fam Cancer 2005; 4: 295-300.
17. Rodriguez-Bigas MA, Boland CR, Hamilton SR et al. A National CancerInstitute Workshop on hereditary nonpolyposis colorectal cancer syndrome:meeting highlights and Bethesda guidelines. J Natl Cancer Inst1997; 89: 1758-1762
18. Levin B, Lieberman DA, McFarland B et al. Screening and surveillance forthe early detection of colorectal cancer and adenomatous polyps, 2008: ajoint guideline from the American Cancer Society, the US Multi-SocietyTask Force on Colorectal Cancer, and the American College of Radiology.Gastroenterology 2008; 134: 1570-1595 (Pubitemid 351615355)
19. Winawer S, Fletcher R, Rex D et al. Colorectal cancer screening and surveillance:clinical guidelines and rationale-Update based on new evidence.Gastroenterology 2003; 124: 544-560
20. Centers for Disease Control and Prevention (CDC). Colorectal cancer testuse-Maryland, 2002-2006. MMWR Morb Mortal Wkly Rep 2007, 932-936
21. SeeffLC, Nadel MR, Klabunde CN et al. Patterns and predictorsof colorectal cancer test use in the adult U.S population. Cancer2004; 100: 2093-2103
22. Bleiker EM, Menko FH, Taal BG et al. Screening behavior of individuals athigh risk for colorectal cancer. Gastroenterology 2005; 128: 280-287
23. Pylvanainen K, Kairaluoma M, Mecklin JP. Compliance and satisfactionwith long-term surveillance in Finnish HNPCC families. Fam Cancer2006; 5: 175-178
24. Schroy PC III, Barrison AF, Ling BS et al. Family history and colorectalcancer screening: a survey of physician knowledge and practice patterns.Am J Gastroenterol 2002; 97: 1031-1036
25. Balmana J, Stockwell DH, Steyerberg EW et al. Prediction of MLH1 andMSH2 mutations in Lynch syndrome. JAMA 2006; 296: 1469-1478
26. Barnetson RA, Tenesa A, Farrington SM et al. Identification and survivalof carriers of mutations in DNA mismatch-repair genes in colon cancer. NEngl J Med 2006; 354: 2751-2763
27. Chen S, Wang W, Lee S et al. Prediction of germline mutations and cancerrisk in the Lynch syndrome. JAMA 2006; 296: 1479-1487
28. Khoja S, McGregor SE, Hilsden RJ. Validation of self-reported history ofcolorectal cancer screening. Can Fam Physician 2007; 53: 1192-1197
29. Partin MR, Grill J, Noorbaloochi S et al. Validation of self-reported colorectalcancer screening behavior from a mixed-mode survey of veterans.Cancer Epidemiol Biomarkers Prev 2008; 17: 768-776
30. Vernon SW, Tiro JA, Vojvodic RW et al. Reliability and validity of a questionnaireto measure colorectal cancer screening behaviors: does mode of surveyadministration matter? Cancer Epidemiol Biomarkers Prev 2008; 17: 758-767
31. Robson ME, Storm CD, Weitzel J et al. American Society of ClinicalOncology policy statement update: genetic and genomic testing for cancersusceptibility. J Clin Oncol 2010; 28: 893-901.
32. American College of Medical Genetics. ACMG statement ondirect-to-consumer testing. http://www.acmg.net/AM/Template.cfm?Section=Terms-and-Conditions & termsreturnurl=Section=Policy-Statements& Template=/CM/ContentDisplay. cfm&ContentID=2975.